Anti-inflammatory and immunomodulative effects of clarithromycin for severe septic patients

Anti-inflammatory and immunomodulative effects of clarithromycin for severe septic patients - Anti-inflammatory and immunomodulative effects of clarithromycin

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021476

Enrollment

Registered

2016-03-15

Start date

2016-03-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe sepsis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult severe septic patients in Tokai University hospital

Exclusion criteria

Exclusion criteria: Under 18.y.o

Design outcomes

Primary

Measure	Time frame
inflammatory cytytokines	—

Secondary

Measure	Time frame
Number and function of immuno cells	—

Countries

Japan

Contacts

Public ContactShigeaki Inoue

Tokai University hospital Dept of Emergency medicine

sg-inoue@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results